Leader of fake Covid vaccine scam arrested in China
Feb 17 2021
Four people in OR tested positive for the coronavirus after receiving both doses of the COVID-19 vaccine, health officials said.
So-called "breakthrough" cases occur 14 days after the second dose of the COVID-19 vaccine is given.
"We are working with our local and federal public health partners to investigate and determine case origin". Genome sequencing is underway, and we expect results next week, "Oregon's Health Authority said in a series of tweets on Friday".
"Clinical trials of both vaccines presently in use included breakthrough cases".
Boris Johnson has said the nation's largest ever vaccination programme will prove "the light at the end of the tunnel" from the pandemic, as he promised 2021 would see the return of the "Great British summer".
As of Monday morning, February 15, at least 38,292,270 people in the USA have received at least one dose of either Pfizer's or Moderna's COVID-19 vaccine, according to the CDC, and 14,077,440 people have gotten both doses. The CDC is now tracking "breakthrough" cases, and OR officials shared their information with the agency.
The drug, which proved 94 per cent effective in protecting against coronavirus in clinical trials, is set to become available in the United Kingdom in as little as two weeks. Should a vaccinated individual contract the virus, the vaccine would also be able to lessen the severity of their symptoms.
OR has become one of the first states to report people contracting COVID-19 after being fully vaccinated.
Sidelinger said these four cases are a good reminder that even if someone is vaccinated, wearing a mask and remaining socially distant is still recommended to slow the spread of the coronavirus.
Nearly 30 government ministers will tour vaccination centres, from sports stadia to cathedrals, to spread the message of the importance of getting a shot amid concern that some groups, such as certain ethnic minorities, are not taking up the offer to the same extent as the rest of the population.
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD for low-and middle-income countries.